Target type: biologicalprocess
Any process that increases the rate, frequency, or extent of the progression of the dermatome over time, from its initial formation to the mature structure. The dermatome is the portion of a somite that will form skin. [GOC:BHF, GOC:dph]
Positive regulation of dermatome development is a crucial biological process that controls the formation of dermatomes, which are the precursor structures for the skin and associated tissues. This process is initiated during embryonic development and involves a complex interplay of signaling pathways, transcription factors, and cell interactions. Here's a detailed breakdown:
1. **Initiation and Specification:**
- The development of dermatomes begins with the formation of the somites, segmented blocks of mesoderm along the developing vertebral column.
- Signaling molecules such as Wnt, Shh, and FGF from the adjacent neural tube and notochord influence the specification of the somite's dorsal region, which will give rise to the dermatome.
2. **Dorsalization and Differentiation:**
- The dorsal region of the somite, the dermomyotome, undergoes further dorsalization, a process driven by the transcription factor Pax3.
- Pax3 activates the expression of other key regulatory genes, including Myf5, which promotes myogenesis (muscle development), and Pax7, which is critical for maintaining the pool of undifferentiated dermatome cells.
3. **Cell Migration and Differentiation:**
- Dermatome cells exhibit extensive migration, spreading along the dorsal surface of the embryo.
- This migration is guided by chemoattractant signals, such as netrin-1, secreted from the neural tube, and is regulated by the interaction between cell adhesion molecules.
- As dermatome cells migrate, they differentiate into various cell types, including fibroblasts, adipocytes (fat cells), chondrocytes (cartilage cells), and melanocytes (pigment cells), contributing to the diverse structures of the skin, subcutaneous tissues, and other associated organs.
4. **Regulation by Signaling Pathways:**
- Multiple signaling pathways play vital roles in dermatome development.
- The Wnt pathway, activated by Wnt proteins, is crucial for dorsalization and the maintenance of the dermomyotome.
- The TGF-beta pathway, activated by TGF-beta family members, promotes cell proliferation and differentiation.
- The Shh pathway, activated by Sonic hedgehog, influences the patterning of the dermomyotome and subsequent tissue formation.
5. **Integration with Other Developmental Processes:**
- Dermatome development is tightly integrated with other developmental processes, such as neural tube formation, muscle development, and limb development.
- Crosstalk between these processes ensures coordinated and appropriate development of the embryo.'
"
Protein | Definition | Taxonomy |
---|---|---|
Protein Wnt-3a | A protein Wnt-3a that is encoded in the genome of human. [PRO:DNx, UniProtKB:P56704] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
CCT251545 | CCT251545 : A chloropyridine that is 3-chloropyridine substituted by a 1-oxo-2,8-diazaspiro[4.5]decan-8-yl group and a 4-(1-methyl-1H-pyrazol-4-yl)phenyl group at positions 4 and 5, respectively. It is an orally bioavailable inhibitor of Wnt signaling (IC50 = 5 nM) and a potent and selective chemical probe for cyclin-dependent kinases CDK8 and CDK19. CCT251545: a Wnt signaling inhibitor; structure in first source | azaspiro compound; chloropyridine; pyrazoles | antineoplastic agent; EC 2.7.11.22 (cyclin-dependent kinase) inhibitor; Wnt signalling inhibitor |
xav939 | XAV939 : A thiopyranopyrimidine in which a 7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine skeleton is substituted at C-4 by a hydroxy group and at C-2 by a para-(trifluoromethyl)phenyl group. XAV939: selectively inhibits beta-catenin-mediated transcription; structure in first source | (trifluoromethyl)benzenes; thiopyranopyrimidine | tankyrase inhibitor |
nvp-tnks656 |